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RegulationOur previous studies demonstrated formation of a complex between acetylated tubulin and brain plasma
membrane Ca2+-ATPase (PMCA), and the effect of the lipid environment on structure of this complex and on
PMCA activity. Deformability of erythrocytes from hypertensive human subjects was reduced by an increase in
membrane tubulin content. In the present study, we examined the regulation of PMCA activity by tubulin in
normotensive and hypertensive erythrocytes, and the effect of exogenously added diacylglycerol (DAG) and
phosphatidic acid (PA) on erythrocyte deformability. Some of the keyﬁndings were that: (i) PMCAwas associated
with tubulin in normotensive and hypertensive erythrocytes, (ii) PMCA enzyme activity was directly correlated
with erythrocyte deformability, and (iii) when tubulin was present in the erythrocyte membrane, treatment
with DAG or PA led to increased deformability and associated PMCA activity. Taken together, our ﬁndings indicate
that PMCA activity is involved in deformability of both normotensive and hypertensive erythrocytes. This rheolog-
ical property of erythrocytes is affected by acetylated tubulin and its lipid environment because both regulate
PMCA activity.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Hypertension is a pathological state associatedwithmultiple factors,
including changes in the properties of erythrocytes and in their hemo-
rheological parameters. These changes include alterations in intracellu-
lar levels of calcium and sodium, erythrocyte deformability index, and
membrane ﬂuidity [1–5]. Intracellular calcium regulates numerous
erythrocyte membrane functions, including control of shape, lipid com-
position, and cation permeability [6,7]. Plasmamembrane Ca2+-ATPase
(PMCA) is a P-type ATPase that plays a crucial role in regulation of
cell calcium homeostasis [8]. We demonstrated in 2008 that tubulin
(primarily the acetylated isotype, termed AcTub) is capable of interact-
ing with PMCA and thereby inhibiting its enzyme activity [9]. However,
the regulatory effect of tubulin on PMCA is not always inhibitory, and is
modulated by the lipids that surround PMCA. In a follow-up 2012 study,
we showed that PMCA activity is enhanced by diacylglycerol (DAG),
phosphatidic acid (PA), or an acidic lipid mixture, and that this enhanc-
ing effect is further promoted by the presence of tubulin [10]. Whenglycerol; PA, phosphatidic acid;
ill remain forever in our hearts.tubulin puriﬁed from rat brain (containing the natural mixture of
isotypes) was mixed with puriﬁed PMCA in the presence of acidic or
neutral lipids, a tubulin/PMCA complexwas formed that showed a pref-
erence for AcTub. The lipid fractions evidently stimulated recruitment of
AcTub during complex formation, because the above preferencewas not
observed in the absence of the lipids [10].
Tubulin in human erythrocytes is distributed into three operationally
distinct fractions that can be isolated by centrifugation procedures:
cytosolic fraction, membrane fraction, and a fraction that sediment at
100,000 ×g [11]. We found that hypertensive subjects, in comparison
with normal subjects, had a higher level of tubulin in themembrane frac-
tion. Total tubulin content was essentially the same, but the protein was
redistributed from the sedimentable fraction to the membrane fraction.
The increased content of tubulin in membrane was correlated with inhi-
bition of Na+,K+-ATPase (NKA), another P-type ATPase. In erythrocytes
from spontaneously hypertensive rats, the progressive increase of tubu-
lin content in erythrocytemembraneswas correlatedwith disease devel-
opment and reduced erythrocyte deformability [12].
The present study was focused on the roles of tubulin, lipids,
and PMCA activity in human erythrocyte deformability. Erythrocyte
deformability was reduced or increased, respectively, by inhibition
or promotion of PMCA activity. AcTub and lipid membrane proper-
ties both affected PMCA activity and thereby regulated erythrocyte
deformability.
Table 1
Demographic and hemodynamic data from the studied populations of normotensive
(N) and hypertensive (H) patients.
Parameters N (n = 30) H (n = 45)
Age (years) 64 ± 11 62 ± 10
Sex (male/female) 18/12 20/25
Weights (Kg) 77 ± 11 80 ± 12
Systolic BP (mm Hg) 110 ± 18 165 ± 22
Diastolic BP (mm Hg) 86 ± 10 103 ± 9
Diabetes Negative Negative
Hypercholesterolemia 0/30 5/45
Antihypertensive treatment – 20/45
Urea (mg/dl) 35 ± 7 34 ± 8
Creatinine (md/dl) 0.72 ± 0.12 0.78 ± 0.11
Na+ (mM) 141 ± 5 139 ± 10
K+ (mM) 6 ± 2 5 ± 1
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2.1. Materials
ATP, mouse anti-α-tubulin mAb DM1A, anti-PMCAmAb 5 F10, anti-
AcTub mAb 6-11B-1, peroxidase-conjugated mouse IgG, ﬂuorescein-
conjugated mouse IgG, 1,2-dicapryloyl-sn-glycerol (DAG), L-α-PA
from egg yolk, nitrocellulose membrane, nocodazole, paclitaxel (taxol),
calcium ionophore A23187 (calcimycin), ouabain, and o-vanadate were
from Sigma Chemical Co. (St. Louis, MO, USA). Anti-phosphatidylinositol
3-kinase (PI3K) p110 mAb Ci was from Santa Cruz Biotechnology.
Lumigen PS-3 detection kit and high-performance chemiluminescence
ﬁlm were from GE Healthcare Life Sciences (Piscataway, NJ, USA).
2.2. Preparation of human erythrocytes
Male and female patients in the SanAntonio de PaduaHospital of Rio
Cuarto (Cordoba, Argentina) were recruited for the study using a proto-
col of informed consent approved by the Human Ethics Committee of
the National University of Rio Cuarto. Demographic data and hemody-
namic of patients are summarized in Table 1. The fresh blood samples
were obtained from healthy volunteers and hypertensive patients'
vacutainer tubes (Becton-Dickinson, Plymouth, UK) using 1 mg/ml of
EDTA as anticoagulant and stored for 96 h at 4 °C. Erythrocytes isolated
by conventional centrifugal separation and immediately are used for ex-
periments. Hypertensive patients were selected on the basis of personal
history of hypertension (according toWHO criteria) consistently N160/
110 mm Hg.
The ~50% of hypertensive patients were treated with antihyperten-
sive drugs. In Figs. 1 and 3 and Table 2 a patient from hypertension
group was treated with anti-hypertensive and in Figs. 2 and 4 two
patients in the group of hypertensive patients were treated with anti-
hypertensive.
2.3. Isolation of erythrocyte membranes
Erythrocytes isolated from 2 ml blood were resuspended in 4 ml
lysis buffer (7.5 mM sodium phosphate, pH 7.5, containing 1 mM
EDTA, and 20 mg/ml PMSF) and incubated for 15 min in ice. The lysate
was centrifuged at 20,000 ×g for 20 min. The pellet was washed three
times with 6 ml lysis buffer without PMSF, resuspended in 0.3 ml lysis
buffer (“membrane fraction”), and stored at−20 °C until use.
2.4. Preparation of Sepharose-linked antibody
Anti-α-tubulin mAb DM1A and anti-PI3K p110 mAb Ci were cova-
lently linked to CNBr-activated Sepharose 4B as described previously
[13], with slight modiﬁcation. Sepharose beads were washed with 100
volumes of 1 mM HCl at 21 °C. The resulting packed beads (1 ml)
were mixed with ascites ﬂuid (2.5 mg protein) containing mAb DM1Aor mAb Ci in 1 ml coupling buffer (0.5 M NaCl containing 0.2 M
NaHCO3, pH 8.2). The mixture was shaken on a platform rocker for
4 h at 21 °C and loaded into a small chromatographic column. Unbound
antibodywas removed bywashingwith 5ml coupling buffer. Antibody-
bound beads were transferred to a beaker and suspended in 1 ml cou-
pling buffer containing 0.2 M glycine to block unreacted Sepharose
sites. The mixture was shaken for 2 h at 21 °C, and unbound glycine
was removed by washing the beads with 10 ml coupling buffer. The
resulting Sepharose-linked antibody was washed with 1.5 ml of
0.01 M Tris/HCl, pH 8.0, containing 0.14 M NaCl and 0.025% NaN3, and
stored at 4 °C until use (maximum 2 days).
2.5. Immunoprecipitation procedure
One volume membrane preparation (5 mg protein/ml) was mixed
with one volumeNaCl/Tris (150mMNaCl, 50mMTris/HCl, pH 7.4) con-
taining 1% Triton X-100 (NaCl/Tris-Triton) and centrifuged to eliminate
residual insolublematerial. Aliquots (0.15ml) weremixedwith 0.15ml
packed antibody-Sepharose beads and incubated 4 h at 20 °C with gen-
tle shaking. Samples were centrifuged, the supernatant was removed,
and precipitated material was washed ﬁve times with NaCl/Tris-
Triton. Fractions (50 μl) of packed beads and supernatant were
resuspended in 50 μl Laemmli sample buffer, heated to 50 °C for
15 min, and centrifuged. Aliquots (20 μl) of soluble fractions were sub-
jected to SDS-PAGE. A control was run in parallel using anti-PI3K p110
mAb Ci, instead of anti-α-tubulin mAb DM1A, linked to Sepharose.
2.6. Preparation and addition of exogenous phospholipids
DAG and PA were kept as 1000-fold concentrated stock solutions in
chloroform, dried prior to use under N2 stream, and emulsiﬁed by son-
ication for 10min in 150mMNaCl, 10mMTris–HCl, pH8.0. DAG and PA
in vesicles were added to intact erythrocytes to a ﬁnal concentration of
50 μM [14,15].
2.7. PMCA activity assay
Enzyme activity of PMCA from erythrocyte membranes (0.5–1.0 mg
protein) was determined using a coupled enzyme assay as described by
Salvador and Mata [16]. In brief, membranes were incubated for 5 min
at 37 °C in a reaction mixture containing 50 mM Tris–HCl, pH 7.4,
20 mM KCl, 100 mM NaCl, 2.5 mM MgCl2, 1 mM ouabain, 0.16 mM
NADH, 0.45 mM phosphoenolpyruvate, 10 IU pyruvate kinase, 28 IU
lactate dehydrogenase, and CaCl2 (sufﬁcient to give free Ca2+ concen-
tration 2.4 μM). Deﬁned concentrations of free Ca2+ were established
using CaCl2/EGTA solutions, and calculated using Webmax C Standard
software. The enzymatic reaction was initiated by addition of 1 mM
ATP. PMCA activitywas calculated as the difference in ATP hydrolysis be-
tween samples incubated in the presence vs. absence of Ca2+ in a ﬁnal
volume of 0.34 ml. NADH oxidation was measured for 15 min at room
temperature at wavelength 340 nm in a recording spectrophotometer.
2.8. Determination of erythrocyte deformability
Erythrocyte deformabilitywas determined using theﬁltrationmeth-
od described by Cabrales [17]. In brief, polycarbonate ﬁlters (Nuclepore/
Whatman; Pleasanton, CA, USA) with a pore size of 5 μm, diameter of
13 mm, and pore density of 4 × 103/mm2 were perfused with diluted
cell suspensions using an infusion pump. Cell suspensions or medium
(buffer) were delivered through the ﬁlter at rates of 0.5, 0.6, 0.7, 0.8,
and 0.9 ml/min. The pressure drop across the ﬁlter was measured
with a differential pressure transducer. Erythrocyte deformability was
assessed by determining the parameters β and ψ. β is the ratio of
(i) the resistance to ﬂow through a ﬁlter pore calculated according to
themethod of Skalak et al. [18,19], using the ratio of the initial pressure
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buffer alone.
β ¼ Pi=Po−1ð Þv=hþ 1
where Pi = pressure drop across the ﬁlter; Po = cells present to the
pressure drop; υ = ratio of mean cell volume to pore volume, and
h = volume packed erythrocyte fraction of the perfusate. Filtration
measurements were made using different ﬁlters, and averaged. The
value of β depends on the ﬂow used to deform the cells. ψ is the slope
of the curve of β vs. ﬂow. An increase of ψ reﬂects a decrease of erythro-
cyte deformability and is independent of the ﬂow used to deform the
cells.2.9. Immunoﬂuorescence microscopy
Erythrocytes were ﬁxed on coverslips with anhydrous methanol at
−20 °C. Samples were rehydrated, incubated with 2% BSA (bovine
serum albumin) in NaCl/Pi (PBS) for 60min, and stained by indirect im-
munoﬂuorescence using mouse anti-α-tubulin mAb DM1A (dilution
1:100) or anti-AcTub mAb 6-11B-1 (dilution 1:200) in NaCl/Pi contain-
ing 1% BSA. Fluorescein-conjugated anti-mouse IgG (dilution 1:200)
was used as secondary antibody. Coverslips were mounted on Fluor-
Save and observed for epiﬂuorescence with a ﬂuorescence microscope
(model H600L; Nikon; Tokyo, Japan). As we demonstrated previously
[11], uniform ﬂuorescence distribution in erythrocytes indicates high
tubulin content in membrane, whereas a ring pattern of ﬂuorescence
indicates localization of tubulin in the sedimentable fraction.2.10. Immunoblotting
Proteins were separated by SDS-PAGE (8% gel for PMCA; 14% gel for
separate tubulin) by the method of Laemmli [20], and transferred to
a nitrocellulose sheet. Blots were reacted with anti-α-tubulin mAb
DM1A (dilution 1:1000), anti-AcTub mAb 6-11B-1 (dilution 1:1000)
[21], or anti-PMCA mAb 5 F10 (dilution 1:1000) [22]. The sheet
was reacted with the corresponding peroxidase-conjugated anti-IgG
antibody (dilution 1:500), and stained using the 4-chloro-1-naphthol
method or the ECL system. Band intensities were quantiﬁed using the
Scion Image software program.Fig. 1. Tubulin/PMCA complex and enzyme activity in membranes of hypertensive (H) and no
and analyzed by immunoblotting with anti-PMCA mAb 5 F10. Precipitate: membranes solubili
DM1A or to anti-PI3K mAb Ci as control. Immunoprecipitate was analyzed by immunoblottin
of membrane protein was loaded in each lane. Optical densities corresponding to PMCA bands
units (A.U.). mAb 5 F10 recognized additional bands at regions corresponding to MW 95 and 5
by ATP hydrolysis in erythrocyte membrane fractions as described in M&M. Values shown are2.11. Protein determination
Protein concentration was determined by the method of Bradford
[23] using BSA as standard.
3. Results
3.1. Tubulin/PMCA complex in erythrocytes from normotensive and
hypertensive subjects
Our previous studies showed that plasma membrane tubulin con-
tent in erythrocytes from normotensive and hypertensive subjects
affects ion transport [11], and that tubulin in brain membranes forms
a complexwith PMCA, resulting in reduced enzymeactivity [9]. Further-
more, Postnov YV et al. found that calcium transport is altered in eryth-
rocyte membranes with essential hypertension [24]. We therefore
investigated the possibility that tubulin/PMCA complex is involved in
PMCA activity regulation in erythrocytes and thereby promotes devel-
opment of hypertension. We immunoprecipitated the complex from
detergent-solubilized erythrocyte membranes using Sepharose beads
coupled to anti-α-tubulin mAb DM1A. PMCA in the immunoprecipitate
and that remaining in the supernatant were detected by Western blot-
ting (Fig. 1). In normotensive erythrocytes, 65% of total PMCA present
in the membrane fraction was precipitated by DM1a (Precipitate “N”),
indicating that most of the enzyme is associated with tubulin. Remain-
ing non-associated PMCA was recovered in the supernatant fraction
(Supernatant “N”). In hypertensive erythrocytes, ~90% of total PMCA
in the membrane fraction was associated with tubulin (Precipitate
“H”). These ﬁndings indicate that the content of tubulin/PMCA com-
plex in erythrocyte membranes is higher for hypertensive than for
normotensive subjects. Therefore, a diminished PMCA activity should
be expected in erythrocytes from hypertensive subjects. In effect,
PMCA activity was 40% lower in hypertensive than in normotensive
erythrocytes (right panel). Taken together, these ﬁndings suggest that
(i) tubulin and PMCA are associated in a complex in erythrocyte mem-
branes, (ii) PMCA activity is regulated by the degree of such association,
and (iii) increased complex formation is the cause of reduced PMCA
activity in hypertensive erythrocytes.
3.2. Effects of DAG and PA on PMCA activity and erythrocyte deformability
Erythrocyte deformability, i.e., their capacity for changing shape
while traveling through blood vessels, is reduced in hypertensivermotensive (N) erythrocytes. Input: membranes were solubilized with 0.5% Triton X-100
zed in detergent were immunoprecipitated with Sepharose linked to anti-α-tubulin mAb
g with mAb 5 F10. Supernatant: upper fraction of immunoprecipitate. An equal quantity
were quantiﬁed using the Scion Image software program. Values are shown as arbitrary
2 KDa; these may represent proteolysis of the pump [38,39]. PMCA activity was measured
mean ± SD from three independent experiments.
Fig. 2. Effects of DAG and PA on erythrocyte deformability and PMCA activity. Normotensive (A) and hypertensive (B) erythrocytes (quantity 1 ml for each) were incubated at 37 °C for
30 min in the absence (■) or presence of 50 μM DAG (●) or PA (▲). Flow resistance (β) through ﬁlter pores was determined as described in M&M. (C) Deformability (ψ) values were
calculated from the slopes of the curves in A and B. PMCA activity was determined by ATP hydrolysis as described in M&M. Values shown are mean ± SD from four independent
experiments.
Table 2
Effects of PMCA inhibitors on erythrocyte deformability.
Deformability (Ψ)
Normotensive Hypertensive
Untreated 80 ± 7 141 ± 18
Vanadate 124 ± 13 140 ± 28
Ouabain 75 ± 11 131 ± 17
A23187 81 ± 13 129 ± 18
A2387 + Ca2+ 142 ± 17 140 ± 18
Hypertensive and normotensive erythrocytes were incubated at 37 °C for 30 min in the
presence of 1 mM vanadate or 1 mM ouabain. In the experiment with Ca2+ ionophore
A23187, cells were incubated with 50 μM of A23187 and then at 37 °C for 30 min in the
absence or presence of sufﬁcient CaCl2 to reach a free Ca2+ concentration of 100 μM.
Cells were washed after treatment and deformability (ψ) was determined as described
in M&M. Values shown are mean ± SD from three independent experiments.
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levels of sodium and calcium ions [12,27]. Our previous studies have
shown that PMCA and NKA activities are regulated by tubulin [9,10,
28–30], and that the regulatory effect on PMCA activity depends on sur-
rounding lipids [10]. In the present study, we examined the regulatory
effects of DAG and PA on PMCA activity and consequently on erythro-
cyte deformability. For determination of erythrocyte deformability, we
measured β (resistance to ﬂow) in normotensive and hypertensive sub-
jects (Fig. 2A, B) and calculated ψ (Fig. 2C). Both β and ψwere lower for
normotensive than for hypertensive erythrocytes, indicating greater
deformability. Consistent with our previous ﬁndings [12], deformability
was ~50% lower for hypertensive than for normotensive erythrocytes
(Fig. 2C, ψ values). Following addition of PA or DAG, deformability
of normotensive erythrocytes increased ~40%, and PMCA activity
increased ~20% (Fig. 2C). DAG or PA treatment of hypertensive erythro-
cytes caused a ~55% increase of deformability and a signiﬁcant increase
in PMCA activity (Fig. 2C).
The observed correlation between increased PMCA activity caused
by DAG and PA and increased erythrocyte deformability suggested
that PMCA activity is involved in the deformability. To test this hypoth-
esis, we assessed deformability following treatment of erythrocytes
with P-ATPase inhibitors. In the presence of 2 mM O-vanadate (a
general P-ATPase inhibitor), the ψ value of normotensive erythrocytes
increased ~55% (Table 2), suggesting that deformability may be depen-
dent on P-ATPase (NKA or PMCA) activity. We next examined erythro-
cyte deformability in the presence of ouabain (1 mM), a selective
inhibitor of NKA activity. Ouabain had no effect on deformability of
either normotensive or hypertensive erythrocytes (Table 2), indicating
that NKA does not play a major role in regulation of deformability. To
investigate the role of PMCA, we determined deformability following
incubation of erythrocytes with the calcium ionophore A23187
(calcimycin) and free calcium, a condition simulating the high calcium
concentration that would occur within erythrocytes in the absence
of PMCA activity. A23187 treatment caused a ~60% decrease indeformability of normotensive erythrocytes, but had no effect on
deformability of hypertensive erythrocytes (in which PMCA activity is
~40% lower than in normotensive erythrocytes) (Table 2). These ﬁnd-
ings indicate that PMCA activity plays an important role in erythrocyte
deformability.
3.3. The effects of DAG on PMCA activity and erythrocyte deformability
depend on membrane tubulin content
The promoting effect of DAG on PMCA activity and erythrocyte
deformabilitywasmore pronounced in hypertensive than in normoten-
sive erythrocytes (Fig. 2C). The fact that membrane tubulin content
is higher in hypertensive erythrocytes [6] suggests that the strong
effect of DAG on deformability is due to a higher content of inhibited
PMCA (resulting from a higher level of tubulin/PMCA complex; Fig. 1)
and thus a greater amount of PMCA available to be re-activated. We
hypothesized that tubulin/PMCA complex helps regulate erythrocyte
deformability through inhibition or de-inhibition of PMCA activity.
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content in normotensive erythrocytes by treatment with taxol or
nocodazole, respectively [12], and then evaluated the effect of DAG on
erythrocyte deformability. Taxol treatment resulted in a ~40% increase
in tubulin content (Fig. 3A,C), in agreement with our previous ﬁnd-
ings [12], and a reduction in PMCA activity and cell deformability
(Fig. 3B,C). Subsequent addition of DAG produced a ~100% increase
in PMCA activity (Fig. 3B), and ~50% increase in deformability
(Fig. 3C). In experiments with hypertensive erythrocytes, DAG treat-
ment (without taxol pre-treatment) increased deformability and PMCA
activity (Figs. 2C, 3C). When cells were pre-treated with nocodazole to
reduce membrane tubulin content (Fig. 3A, C), DAG had no effect on
deformability or PMCA activity of normotensive erythrocytes (Fig. 3B).
When the various experiments described above were performed with
PA instead of DAG, the results obtained were similar to those with
DAG (data not shown). Taken together, our ﬁndings indicate that the
effect of DAG on erythrocyte deformability and PMCA activity depends
on membrane tubulin content; the higher the tubulin content, the
greater the promoting effect of DAG on deformability.
3.4. Effects of DAG and PA on distributions of total tubulin and AcTub in
erythrocytes
In our previous studies on rat brain membranes, regulation of PMCA
activity through tubulin/PMCA complex showed a preference for the
AcTub isotype [9]. In in vitro experiments using artiﬁcial vesicles, acidicFig. 3. Effects of taxol, nocodazole, andDAG on erythrocyte deformability, PMCA activity, andme
1 h at 37 °C in the absence (CN) or presence of 50 μMnocodazole (NOC). Normotensive (but no
ments, the cells were incubated for 30minwith 50 μMDAG. (A)Membraneswere obtained from
anti-tubulin mAb DM1A. Volumes loaded on each well were calculated to represent equivalent
and tubulin contents for each lanewere expressed as percentages of corresponding values for u
another aliquot of normotensive erythrocyte suspensionwere subjected to determination of PM
in Panel A (three independent experiments) were quantiﬁed and expressed as arbitrary units
nation of ﬂow resistance (β; not shown) and deformability (Ψ). Values shown are mean ± SDor neutral lipids increased AcTub content in the hydrophobic phase
when PMCA was present [10]. The effect of DAG on erythrocyte
deformability observed in the present study may therefore be due to a
lipid-induced change in AcTub distribution, since AcTub is involved
in regulation of PMCA activity. This possibility was tested by treating
normotensive and hypertensive erythrocytes with DAG or PA and
analyzing distribution of total tubulin and AcTub by indirect immuno-
ﬂuorescence with mAbs DM1A and 6-11B-1, respectively. Tubulin in
erythrocytes appears as a sedimentable structure in membrane and
soluble fractions [11,12]. In immunoﬂuorescence techniques, the sedi-
mentable structure is seen as a ﬂuorescent ring in the erythrocyte
periphery, whereas membrane tubulin is seen uniformly in the entire
erythrocyte [11,12]. In normotensive erythrocytes, DAG or PA treatment
had no effect on total tubulin distribution (Fig. 4). Following DM1A
staining, ﬂuorescence was concentrated at the periphery, indicating
that total tubulinwasmostly in sedimentable form (Fig. 4A). In contrast,
DAG or PA treatment did affect AcTub distribution; AcTub (as revealed
by 6-11B-1 staining) was concentrated at the periphery before DAG or
PA treatment but migrated to the membrane following treatment
(Fig. 4A).
In hypertensive erythrocytes, total tubulin was found mainly in
the membrane. Following DAG or PA treatment, total tubulin was
translocated to sedimentable structures, whereas AcTub remained at
the membrane (Fig. 4A). To conﬁrm this ﬁnding, membranes from nor-
motensive and hypertensive erythrocyteswere isolated, andmembrane
AcTub was quantiﬁed by immunoblotting. DAG or PA treatment causedmbrane tubulin content. Normotensive and hypertensive erythrocyteswere incubated for
t hypertensive) erythrocytes were incubated with 5 μM taxol (TX). Following these treat-
an aliquot of erythrocyte suspension and subjected to immunoblotting and stainingwith
amounts of erythrocytes. Optical densities were determined by the Scion Image program,
ntreated (CN) normotensive and hypertensive erythrocytes. (B)Membranes isolated from
CAactivity by ATP hydrolysis as described inM&M. (C) Top line: values for tubulin bands as
(A.U.). Bottom line: Other aliquots of erythrocyte suspensions were subjected to determi-
from three independent experiments.
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sive erythrocytes (Fig. 4B). These ﬁndings indicate that DAG and PA
treatment caused a redistribution of both total tubulin and AcTub in
erythrocytes. These lipids increased AcTub content in erythrocytemem-
branes, similarly to our previous ﬁndings for acidic and neutral lipids in
artiﬁcial vesicles [10].
4. Discussions
In hypertension, altered transport of sodium and calcium ions
through the erythrocyte membrane leads to changes in characteristics
and physical properties of erythrocytes [26]. Findings from our previous
studies [9–12] and the present study indicate that both membrane
tubulin and membrane lipid composition are involved in regulation of
erythrocyte deformability through their effects on PMCA activity. Eryth-
rocyte deformability was directly correlated with PMCA activity.
Deformability was minimal when PMCA was inhibited, either by in-
creased membrane tubulin in hypertensive erythrocytes (Fig. 2B [com-
pare ψ and PMCA activity values], Fig. 3A), or by enzyme inhibitors such
as vanadate (Table 2). Deformability was maximal when PMCA activity
was increased by reduction of membrane tubulin content in normoten-
sive erythrocytes (Figs. 2, 3), or in the presence of DAG and tubulin
(Fig. 3). Erythrocyte deformability thus appears to be controlled by
membrane tubulin content and lipid composition, both of which regu-
late PMCA activity.We found that erythrocytes of spontaneously hyper-
tensive rats displayed lower deformability and greater resistance to
ﬂow, resulting in increased blood pressure. Treatment of these rats
with nocodazole (which reduces membrane tubulin content) resulted
in blood pressure values similar to those of control (Wistar) rats [12].
Altered deformability of hypertensive erythrocytes through modiﬁca-
tion of PMCA activity by lipid addition or tubulin redistribution, as in
the present study, presumably also has a direct effect on blood pressure.
PMCA activity is regulated by phosphorylation (by protein kinases A
and C), interaction with acidic phospholipids, the dimerization (oligo-
merization) process, autoinhibition, interactionwith a variety of partner
proteins (including tubulin, actin, MAGUK, CLP36, NOS-1, and NHERF2)
and, most importantly, interaction with calmodulin [9,31–34]. We
showed recently that tubulin inhibits PMCA embedded in homogenate
of rat brain cell plasma membranes [9]. This inhibitory effect was
dependent on the lipid composition of the membrane in which the en-
zyme was embedded. In the presence of acidic or neutral lipids, tubulin
activated, rather than inhibited, the enzyme [10]. The present study
gave similar ﬁndings in human erythrocytes. High membrane tubulin
content (as in hypertensive erythrocytes [11]) caused inhibition of
PMCA activity (Fig. 1). DAG or PA treatment of such high-tubulin cells
increased the PMCA activity (Fig. 2). In previous studies, the promoting
effect of DAG and PA on PMCA activity was observed even in the ab-
sence of tubulin [10,35]. In contrast, the promoting effect of DAG and
PA on enzyme activity in the present study was more pronounced in
the presence of tubulin (Fig. 3). This ﬁnding suggests that regulation
of PMCA activity in erythrocytes depends primarily on formation of
tubulin/PMCA complex. Increased level of the complex resulted in
lower enzyme activity. The enzyme activity could be increased again
either by removingmembrane tubulin or adding acidic or neutral lipids.
Our previous study demonstrated that AcTub acquires hydrophobic
properties when it interacts with PMCA. When partitioned with Triton
X-114 in artiﬁcial vesicles containing PMCA, hydrophilic AcTub was
partitioned into the hydrophobic phase because of its association with
PMCA [10]. In artiﬁcial vesicles containing PMCA and acidic or neutralFig. 4. Effects of DAG and PA on tubulin distribution in erythrocytes. (A) Left: distributions of
determined by indirect immunoﬂuorescence using anti-α-tubulinmAb DM1A and anti-AcTubm
(three individual cells for each case). Fluorescence intensity is expressed as arbitrary units (A.
described in M&M. AcTub amount was determined for an aliquot from each treatment by immu
equivalent amounts of erythrocytes. The result from a typical experiment is shown. Tubulin ba
units (mean ± SD from three independent experiments).lipids, the lipids caused an increased content of AcTub in the hydropho-
bic phase [10]. Similar results were obtained with human erythrocytes
in the present study. DAG and PA both increasedmembrane AcTub con-
tent in normotensive and hypertensive erythrocytes (Fig. 4A). Acidic
and neutral lipids evidently promoted association of AcTub with the
erythrocyte membrane and thereby promoted PMCA activity. Con-
versely, recruitment of lipid-free AcTub to the membrane inhibited
enzyme activity. The molecular mechanisms underlying these effects
remain unclear. We have observed that tubulin binds to cytoplasmic
domain (CD) 2 and 3 of PMCA (Carbajal A, Arce C, unpubl. data). Fur-
thermore, the acidic phospholipids bind to two sites in the enzyme,
one in the calmodulin-binding site (in the C-terminus), the other in
CD2 [36]. One possibility is that acidic lipids prevent interaction of tubu-
lin with the CD3 site, in which case tubulin is still capable of anchoring
to PMCA (because of its binding to CD2) but its inhibitory effect is lost.
PMCA would still be activated, primarily because CD3 is the domain for
ATP hydrolysis [36]. In the absence of acidic lipids, tubulin could bind to
the CD2 and CD3 sites and thereby inhibit the enzyme activity. Experi-
ments to test this hypothesis are underway.
Numerous biochemical and hematological parameters are altered
in hypertensive patients. Here we only take into account the criteria
of high blood pressure and membrane tubulin and we found that
tubulin/PMCA/DAG regulates erythrocytes deformability regardless
of the abovementioned parameters. It is possible that differences in
the above parameters can affect patients PMCA activity (and thus the
deformability of erythrocytes) but the data presented here (Figs. 2
and 3) suggest that membrane tubulin and DAG affect the erythrocyte
deformability. Subsequent studies in groups with differences in bio-
chemical and hematological parameters will elucidate other pathways
of affecting the deformability of erythrocytes, affecting either PMCA
activity or not.
The change in erythrocyte deformability has been attributed to
changes in theﬂuidity of the cellmembrane,ﬂexibility of themembrane
skeleton, the viscosity of the cytoplasm, and the cell membrane surface
area to cell volume ratio [37]. Furthermore, aggregation structures
called “rouleaux” in human erythrocytes containing high concentration
of intracellular calcium were observed [27]. Kaczmarska et al. [37]
determined that erythrocytes frompatientswith essential hypertension
increase the fraction of oval cells and these cells also addedmore easily.
We have not found these structures in samples of erythrocytes of hyper-
tensive patients (Fig. 4), because the methodology we use does not
allow us to visualize the ﬁndings of these authors. Anyway, the dif-
ference in hematocrit between patients was less than 3% (data not
shown) which does not seem signiﬁcantly different in deformability.
This allows us to speculate that neither aggregation nor increased eryth-
rocytes would cause the decrease of its deformability. We hypothesized
that the increased membrane tubulin with inhibiting PMCA, leading to
an increase in intracellular calcium, might affect the rheological proper-
ties of the membrane (for example, membrane ﬂuidity and elasticity)
which leads to a change in erythrocyte deformability. Experiments are
in progress to elucidate this aspect.
The combined effects of lipids and tubulin play essential roles in cell
physiology. Membrane lipid composition and PMCA distribution vary
depending on the cell type, the region of the cell, and the physiological
state of the cell. Cellular signaling mechanisms may be modiﬁed by
changes in lipid type and concentration and/or tubulin concentration,
resulting in promotion or inhibition of PMCA activity. Modulation of
PMCA activity depends not only on lipid type and concentration but
also on changes in membrane structure and consequent alterationα-tubulin (Total Tub.) and AcTub in normotensive and hypertensive erythrocytes were
Ab 6-11-B1 as described inM&M. Right: distribution of ﬂuorescencewithin erythrocytes
U). E.D: erythrocyte diameter. (B) Membrane fractions were obtained from 2 ml blood as
noblotting with mAb 6-11-B1. Volumes loaded on each well were calculated to represent
nds were quantiﬁed using the Scion Image program and values are expressed as arbitrary
2820 N.E. Monesterolo et al. / Biochimica et Biophysica Acta 1848 (2015) 2813–2820of rheological erythrocyte deformability as observed in the present
study. For example, such rheological changes could be triggered by acti-
vationof phospholipase C orDwhich catalyzeDAGproduction, and sub-
sequent promotion or inhibition of PMCA activity as a function of
tubulin concentration [10]. Studies are underway in our laboratory to
identify signaling pathways that induce changes in lipid composition
or tubulin concentration, resulting in alteration of localized PMCA activ-
ity and erythrocyte deformability.
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